View Archived Issues
Measuring, paying for quality
CMS changes the rules in Stage 2 Meaningful Use
Managing Change in the dialysis setting
Enforcing HIPAA rules
Next steps for QIP
Will new mandates knock out the competition?
A crucial lifeline: Reducing mortality in the first 120 days
A new player: Affymax wins approval for a new anemia drug
End-Of-Life Care: A multidisciplinary review
Reducing hospital readmissions for ESRD patients
Renal Politics: Election year could stall progress
Is there enough incentive in the QIP?